New research finds that obesity can trigger genetic modifications within fat cells that allow the cells to store "memories" of being overweight in their nucleus and make it easier to regain weight.

Axovia Therapeutics Unveils New Preclinical Data for AXV-201, for Treatment of Genetic Obesity Caused by MC4R Mutations, at ASGCT Provided by GlobeNewswire May 15, 2025, 11:00:00 AM ...

A landmark new study has found that obese teens who are given semaglutide weight loss drugs like Ozempic and Wegovy, may see an improvement in their mental health, including a reduced risk of suicide.

Find out about new obesity drugs currently in phase III clinical trials and how well these medicines might work. ... . cAMP boosts the signals that trigger insulin release and slow stomach emptying.

Motion sickness brain circuit may provide new options for treating obesity . Taylor Barnes. 713-798-4710. Houston, TX - Mar 24, 2025. ... Mouse models offer an abundance of molecular and genetic tools ...

A brand new candidate for weight-loss treatment is on ... a further genetic study of 2,000 obese individuals led to the discovery of an ... thus providing a potential new avenue to treat obesity." ...

Neurotrophins play a crucial role for the function of nerve cells, and a disturbed function of BDNF has a strong genetic link to impaired cognitive ability in several different diseases, such as ...

Now new research at Memorial Sloan Kettering Cancer Center (MSK) suggests obesity may also be linked to some genetic mutations that drive specific subtypes of cancer. “Our results show that obesity ...

Rethinking the way we define obesity could help millions of people worldwide, argue a team of researchers who want to introduce a new category of “preclinical” obesity.

With new treatments that cost upwards of $1,000 per person per month, along with supply shortages, how to define obesity is more than just a fight over nomenclature.

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes. By Brendan Borrell When Stephane Castel first ...